Iris Acquisition Corp (IRAA)

NASDAQ: IRAA · IEX Real-Time Price · USD
10.63
+0.01 (0.09%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Market Cap 77.67M
Revenue (ttm) n/a
Net Income (ttm) 5.78M
Shares Out 7.31M
EPS (ttm) 0.11
PE Ratio 96.64
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Open 10.63
Previous Close 10.62
Day's Range 10.62 - 10.76
52-Week Range 10.11 - 11.22
Beta 0.03
Analysts n/a
Price Target n/a
Earnings Date Jan 6, 2023

About IRAA

Iris Acquisition Corp does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. Iris Acquisition Corp was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp operates as a subsidiary of Iris Acquisition Holdings LLC. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Mar 5, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol IRAA
Full Company Profile

Financial Performance

Financial Statements

News

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

NEW YORK & LONDON--(BUSINESS WIRE)--Liminatus Pharma LLC (“Liminatus”), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp (“Ir...

1 year ago - Business Wire